Annual Accounts Payable
$6.26 M
+$846.00 K+15.63%
December 31, 2023
Summary
- As of February 7, 2025, FHTX annual accounts payable is $6.26 million, with the most recent change of +$846.00 thousand (+15.63%) on December 31, 2023.
- During the last 3 years, FHTX annual accounts payable has risen by +$2.58 million (+70.11%).
- FHTX annual accounts payable is now at all-time high.
Performance
FHTX Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$3.45 M
-$1.36 M-28.30%
September 30, 2024
Summary
- As of February 7, 2025, FHTX quarterly accounts payable is $3.45 million, with the most recent change of -$1.36 million (-28.30%) on September 30, 2024.
- Over the past year, FHTX quarterly accounts payable has dropped by -$3.04 million (-46.88%).
- FHTX quarterly accounts payable is now -52.65% below its all-time high of $7.29 million, reached on March 31, 2023.
Performance
FHTX Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
FHTX Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +15.6% | -46.9% |
| 3 y3 years | +70.1% | -52.6% |
| 5 y5 years | +210.8% | -52.6% |
FHTX Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +63.9% | -52.6% | at low |
| 5 y | 5-year | at high | +82.0% | -52.6% | +18.6% |
| alltime | all time | at high | +210.8% | -52.6% | +18.6% |
Foghorn Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $3.45 M(-28.3%) |
| Jun 2024 | - | $4.81 M(-14.5%) |
| Mar 2024 | - | $5.63 M(-10.0%) |
| Dec 2023 | $6.26 M(+15.6%) | $6.26 M(-3.6%) |
| Sep 2023 | - | $6.50 M(-6.3%) |
| Jun 2023 | - | $6.93 M(-4.9%) |
| Mar 2023 | - | $7.29 M(+34.6%) |
| Dec 2022 | $5.41 M | $5.41 M(+3.0%) |
| Sep 2022 | - | $5.26 M(+44.6%) |
| Jun 2022 | - | $3.63 M(-28.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $5.07 M(+32.8%) |
| Dec 2021 | $3.82 M(+3.8%) | $3.82 M(-0.1%) |
| Sep 2021 | - | $3.82 M(+12.2%) |
| Jun 2021 | - | $3.41 M(+17.0%) |
| Mar 2021 | - | $2.91 M(-20.9%) |
| Dec 2020 | $3.68 M(+7.0%) | $3.68 M(+3.5%) |
| Sep 2020 | - | $3.55 M(+19.2%) |
| Jun 2020 | - | $2.98 M(-13.3%) |
| Dec 2019 | $3.44 M(+70.8%) | $3.44 M |
| Dec 2018 | $2.01 M | - |
FAQ
- What is Foghorn Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Foghorn Therapeutics?
- What is Foghorn Therapeutics annual accounts payable year-on-year change?
- What is Foghorn Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Foghorn Therapeutics?
- What is Foghorn Therapeutics quarterly accounts payable year-on-year change?
What is Foghorn Therapeutics annual accounts payable?
The current annual accounts payable of FHTX is $6.26 M
What is the all time high annual accounts payable for Foghorn Therapeutics?
Foghorn Therapeutics all-time high annual accounts payable is $6.26 M
What is Foghorn Therapeutics annual accounts payable year-on-year change?
Over the past year, FHTX annual accounts payable has changed by +$846.00 K (+15.63%)
What is Foghorn Therapeutics quarterly accounts payable?
The current quarterly accounts payable of FHTX is $3.45 M
What is the all time high quarterly accounts payable for Foghorn Therapeutics?
Foghorn Therapeutics all-time high quarterly accounts payable is $7.29 M
What is Foghorn Therapeutics quarterly accounts payable year-on-year change?
Over the past year, FHTX quarterly accounts payable has changed by -$3.04 M (-46.88%)